SPECTRUM PHARMACEUTICALS INC's ticker is SPPI and the CUSIP is 84763A108. A total of 142 filers reported holding SPECTRUM PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 11.38 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $1,095,000 | +42.6% | 849,041 | +40.4% | 0.01% | +50.0% |
| Q4 2021 | $768,000 | -40.0% | 604,941 | +3.0% | 0.00% | -42.9% |
| Q3 2021 | $1,280,000 | -42.8% | 587,293 | -1.6% | 0.01% | -41.7% |
| Q2 2021 | $2,238,000 | +249.7% | 596,913 | +203.9% | 0.01% | +200.0% |
| Q1 2021 | $640,000 | +1042.9% | 196,438 | +1102.2% | 0.00% | – |
| Q4 2020 | $56,000 | -5.1% | 16,340 | +12.1% | 0.00% | – |
| Q3 2020 | $59,000 | +20.4% | 14,576 | 0.0% | 0.00% | – |
| Q2 2020 | $49,000 | -69.9% | 14,576 | -79.3% | 0.00% | -100.0% |
| Q1 2020 | $163,000 | -84.3% | 70,259 | -75.4% | 0.00% | -80.0% |
| Q4 2019 | $1,039,000 | -74.9% | 285,541 | -42.8% | 0.01% | -73.7% |
| Q3 2019 | $4,142,000 | -16.5% | 499,286 | -13.3% | 0.02% | -13.6% |
| Q2 2019 | $4,958,000 | -13.5% | 575,866 | +7.3% | 0.02% | -12.0% |
| Q1 2019 | $5,735,000 | +51.2% | 536,518 | +23.8% | 0.02% | +38.9% |
| Q4 2018 | $3,792,000 | -67.1% | 433,366 | -36.9% | 0.02% | -58.1% |
| Q3 2018 | $11,536,000 | -10.2% | 686,655 | +12.0% | 0.04% | -15.7% |
| Q2 2018 | $12,849,000 | +33.3% | 613,037 | +2.3% | 0.05% | +34.2% |
| Q1 2018 | $9,641,000 | -16.3% | 599,175 | -1.5% | 0.04% | -11.6% |
| Q4 2017 | $11,523,000 | +20.1% | 608,075 | -10.8% | 0.04% | +13.2% |
| Q3 2017 | $9,592,000 | +66.8% | 681,736 | -11.7% | 0.04% | +65.2% |
| Q2 2017 | $5,751,000 | -9.4% | 771,973 | -21.0% | 0.02% | -11.5% |
| Q1 2017 | $6,349,000 | +71.2% | 976,767 | +16.7% | 0.03% | +52.9% |
| Q4 2016 | $3,708,000 | -2.0% | 837,126 | +3.4% | 0.02% | -5.6% |
| Q3 2016 | $3,782,000 | -40.2% | 809,849 | -15.8% | 0.02% | -41.9% |
| Q2 2016 | $6,321,000 | -10.6% | 962,167 | -13.5% | 0.03% | -11.4% |
| Q1 2016 | $7,071,000 | +34.6% | 1,111,804 | +27.6% | 0.04% | +34.6% |
| Q4 2015 | $5,255,000 | +17.7% | 871,474 | +16.7% | 0.03% | +8.3% |
| Q3 2015 | $4,464,000 | -2.8% | 746,495 | +11.2% | 0.02% | +4.3% |
| Q2 2015 | $4,591,000 | +13.1% | 671,285 | +0.3% | 0.02% | +9.5% |
| Q1 2015 | $4,061,000 | +63.9% | 668,971 | +87.1% | 0.02% | +61.5% |
| Q4 2014 | $2,477,000 | -11.6% | 357,452 | +3.8% | 0.01% | -7.1% |
| Q3 2014 | $2,802,000 | -2.1% | 344,243 | -2.2% | 0.01% | 0.0% |
| Q2 2014 | $2,863,000 | +83.4% | 352,151 | +76.9% | 0.01% | +100.0% |
| Q1 2014 | $1,561,000 | +44.7% | 199,089 | +63.3% | 0.01% | +40.0% |
| Q4 2013 | $1,079,000 | +70.7% | 121,913 | +61.8% | 0.01% | +66.7% |
| Q3 2013 | $632,000 | -1.6% | 75,352 | -12.4% | 0.00% | 0.0% |
| Q2 2013 | $642,000 | – | 86,036 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 6,963,756 | $145,960,000 | 9.42% |
| Avoro Capital Advisors LLC | 3,419,818 | $71,679,000 | 2.76% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 300,000 | $6,285,000 | 2.41% |
| Cormorant Asset Management, LP | 1,200,000 | $25,152,000 | 1.86% |
| Sio Capital Management, LLC | 143,550 | $3,009,000 | 1.66% |
| ASHFORD CAPITAL MANAGEMENT INC | 425,702 | $8,923,000 | 1.18% |
| PURA VIDA INVESTMENTS, LLC | 130,700 | $2,739,000 | 1.10% |
| Sonora Investment Management, LLC | 298,967 | $6,266,000 | 0.97% |
| PURA VIDA INVESTMENTS, LLC | 100,000 | $2,096,000 | 0.84% |
| J. Goldman & Co LP | 694,338 | $14,553,000 | 0.75% |